The contribution of innovative pharmaceutical companies to human health and well-being often goes unnoticed. Yet, the impact is profound. Medicines developed by the industry don’t just treat illnesses – they save lives, restore health, and improve quality of life. By enabling faster recovery, reducing complications, and minimising the need for hospitalisation or surgery, they also help to lower the overall burden on the healthcare system.

Modern treatments are becoming safer, simpler to use, and more effective. Thanks to advancements in delivery systems and reduced side effects, patients are now more likely to adhere to their treatment plans. As a result, we are increasingly able to prevent life-altering outcomes such as strokes, amputations, or heart attacks especially in chronic conditions like diabetes and hypertension.

Diseases that were once life-threatening, such as polio, TB, malaria, and even certain cancers, can now be prevented or effectively treated. But the work is far from over.

Innovation remains essential as we face new health threats from emerging infectious diseases to antibiotic resistance and growing unmet medical needs. Addressing these challenges requires a united, long-term commitment from all healthcare stakeholders.

IPASA and its members believe that through sustained innovation, strategic partnerships, and a shared dedication to patient well-being, we can continue to advance treatments, close access gaps, and build a healthier South Africa for all.